Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (571-580 of 645) with videos related to

Pageof 65
Sort By:
American Journal of Hematology|June 7, 2016
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patientsPaola Guglielmelli, Giada Rotunno, Annalisa Pacilli, et al.
Blood|October 2, 2015
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasmsJelena D Milosevic Feenstra, Harini Nivarthi, Heinz Gisslinger, et al.
Blood Advances|January 18, 2022
Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCsGeorgios Asimomitis, André G Deslauriers, Andriana G Kotini, et al.
Blood|April 21, 2017
Clinical significance of somatic mutation in unexplained blood cytopeniaLuca Malcovati, Anna Gallì, Erica Travaglino, et al.
American Journal of Hematology|December 23, 2011
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignanciesAna Puda, Jelena D Milosevic, Tiina Berg, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 14, 2011
Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthmaChristopher A Hewson, Sheena Patel, Luigino Calzetta, et al.
Leukemia|April 4, 2019
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndromeElisa Bono, Donal McLornan, Erica Travaglino, et al.
The Journal of Clinical Investigation|April 25, 2017
The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromesBon Ham Yip, Violetta Steeples, Emmanouela Repapi, et al.
Blood|June 28, 2014
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasiaLuca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio, et al.
Blood|December 25, 2013
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomesElisa Rumi, Daniela Pietra, Virginia Ferretti, et al.
Pageof 65

Showing results (571-580 of 645) with videos related to

Sort By:
Pageof 65
American Journal of Hematology|June 7, 2016
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patientsPaola Guglielmelli, Giada Rotunno, Annalisa Pacilli, et al.
Blood|October 2, 2015
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasmsJelena D Milosevic Feenstra, Harini Nivarthi, Heinz Gisslinger, et al.
Blood Advances|January 18, 2022
Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCsGeorgios Asimomitis, André G Deslauriers, Andriana G Kotini, et al.
Blood|April 21, 2017
Clinical significance of somatic mutation in unexplained blood cytopeniaLuca Malcovati, Anna Gallì, Erica Travaglino, et al.
American Journal of Hematology|December 23, 2011
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignanciesAna Puda, Jelena D Milosevic, Tiina Berg, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 14, 2011
Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthmaChristopher A Hewson, Sheena Patel, Luigino Calzetta, et al.
Leukemia|April 4, 2019
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndromeElisa Bono, Donal McLornan, Erica Travaglino, et al.
The Journal of Clinical Investigation|April 25, 2017
The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromesBon Ham Yip, Violetta Steeples, Emmanouela Repapi, et al.
Blood|June 28, 2014
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasiaLuca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio, et al.
Blood|December 25, 2013
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomesElisa Rumi, Daniela Pietra, Virginia Ferretti, et al.
Pageof 65